9 Meters Biopharma Inc. (NASDAQ:NMTR) went down by -2.06% from its latest closing price compared to the recent 1-year high of $2.26. The company’s stock price has collected -3.55% of loss in the last five trading sessions. Press Release reported on 02/19/21 that Thinking about buying stock in Gevo, Remark Holdings, 9 Meters Biopharma, Vertex Energy, or Grupo Supervielle?
Is It Worth Investing in 9 Meters Biopharma Inc. (NASDAQ :NMTR) Right Now?
Plus, the 36-month beta value for NMTR is at -3.69. Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for 9 Meters Biopharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $4.75. NMTR currently public float of 116.68M and currently shorts hold a 4.93% ratio of that float. Today, the average trading volume of NMTR was 10.97M shares.
NMTR’s Market Performance
NMTR stocks went down by -3.55% for the week, with a monthly jump of 54.47% and a quarterly performance of 96.40%, while its annual performance rate touched 175.36%. The volatility ratio for the week stands at 10.05% while the volatility levels for the past 30 days are set at 12.65% for 9 Meters Biopharma Inc.. The simple moving average for the period of the last 20 days is 15.57% for NMTR stocks with a simple moving average of 131.08% for the last 200 days.
NMTR Trading at 48.62% from the 50-Day Moving Average
After a stumble in the market that brought NMTR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.93% of loss for the given period.
Volatility was left at 12.65%, however, over the last 30 days, the volatility rate increased by 10.05%, as shares surge +52.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +126.19% upper at present.
During the last 5 trading sessions, NMTR fell by -3.55%, which changed the moving average for the period of 200-days by +322.22% in comparison to the 20-day moving average, which settled at $1.6765. In addition, 9 Meters Biopharma Inc. saw 121.19% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at NMTR starting from Sirgo Mark A, who purchase 230,769 shares at the price of $0.65 back on Dec 15. After this action, Sirgo Mark A now owns 774,066 shares of 9 Meters Biopharma Inc., valued at $150,000 using the latest closing price.
Temperato John, the Chief Executive Officer of 9 Meters Biopharma Inc., purchase 153,846 shares at $0.65 during a trade that took place back on Dec 15, which means that Temperato John is holding 977,522 shares at $100,000 based on the most recent closing price.